6:49am ET
Investing
The 6 Most Shorted NYSE Stocks in May
AT&T continued to reign as the most shorted stock trading on the New York Stock Exchange between the May 15 and May 29 settlement dates.
Companies
/Healthcare
Abbvie Inc
$256.46
▼ $3.75 (−1.44%) today
Markets closed · 8:50am ET
ABBV Coverage
Page 39
1:00pm ET
Health and Healthcare
Autoimmune Drugs to Drive Big Pharma Higher in Coming Years
Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical companies in its coverage.
10:30am ET
Health and Healthcare
How Halozyme Will Continue to Grow With Its New Deal
Halozyme Therapeutics has announced a global collaboration and license agreement with AbbVie.
8:50am ET
Health and Healthcare
The 4 Overlooked Winners of ASCO
ThinkstockThe American Society of Clinical Oncology’s (ASCO) annual meeting is coming to a close. Companies and cancer drug developers across the health care sector flock to this conference to share results from…
9:30am ET
Health and Healthcare
Short Sellers More Selective on Big Pharma Stocks
The short interest data has been released for the May 15 settlement date and for the selected pharmaceutical stocks, short interest is mixed.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: Ambarella, eBay, Rite Aid, TiVo, Yahoo, Valero, Virtu and More
Wednesday's top analyst upgrades, downgrades and initiations include Ambarella, eBay, Rite Aid, TiVo, Yahoo, Valero Energy and Virtu Financial.
9:15am ET
Health and Healthcare
Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy
With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug treatments, the big pharmaceutical stocks have had their fair share of attention…
9:50am ET
Health and Healthcare
Short Sellers Keep Strong Bets Against Big Pharma
The April 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
10:00am ET
Health and Healthcare
Huge Buyout Highlights 4 Deutsche Bank Biotech Focus Stocks
In a new report, Deutsche Bank acknowledges that while the industry has shown recent weakness, now may be just the right time to add biotech stocks.
10:50am ET
Health and Healthcare
Top Credit Suisse Major Pharma Stock Picks to Buy
Credit Suisse has released a report that detailed its top picks for pharmaceutical stocks for the rest of 2015.
8:30am ET
Investing
5 Cheap Large Cap Stocks to Buy in an Expensive Stock Market
A new report from Deutsche Bank highlights all of the known risks and focuses in on stocks that are reasonable in a pricey market.
9:10am ET
Health and Healthcare
3 Big Pharmaceutical Stocks Will Have Rising Q1 Earnings
In a new report, Cowen analysts have sights set on three major pharmaceutical stocks that they expect to have rising first-quarter earnings.
8:55am ET
Investing
Should Investors Buy These 4 ‘Bad News’ Stocks for Big Gains?
24/7 Wall St. has found four good examples of blue-chip stocks that got a little tarnished recently for one reason or another, that investors may want to reexamine.
8:20am ET
Health and Healthcare
The Next 3 Likely Biotech Buyout Candidates
Here are three biotech stocks that a SunTrust analyst feels could be buyout candidates, in the wake of the Pharmacyclics acquisition.
10:40am ET
Health and Healthcare
Just How Expensive Is the Pharmacyclics Buyout?
News finally broke late Wednesday that there was an official buyout of Pharmacyclics in the works by AbbVie for $21 billion.